Current Medical and Surgical Stroke Prevention Therapies for Patients with Carotid Artery Stenosis
Mirza Jusufovic1, Karolina Skagen1, Kirsten Krohg-Sørensen2,3
1Department of Neurology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Insights
Patients with symptomatic carotid artery stenosis (CAS) benefit from early intervention like carotid endarterectomy (CEA) or stenting to reduce stroke risk. Optimal management for asymptomatic CAS is still debated.
Area of Science:
- Vascular Surgery
- Neurology
- Cardiology
Background:
- Carotid Artery Stenosis (CAS) indicates systemic atherosclerosis.
- Patients with CAS face a high risk of vascular events, including ischemic stroke.
- Both medical and surgical treatments can mitigate this risk.
Purpose of the Study:
- To review the current understanding of Carotid Artery Stenosis management.
- To highlight the benefits of revascularization for symptomatic CAS.
- To address the ongoing controversy regarding asymptomatic CAS treatment.
Main Methods:
- Review of existing clinical trial data and guidelines.
- Analysis of risk-benefit profiles for different treatment modalities.
- Focus on the timing of intervention for symptomatic patients.
Main Results:
- Carotid Endarterectomy (CEA) effectively reduces stroke risk in symptomatic CAS (≥70%).
- Early intervention (within 2 weeks) with CEA or stenting is crucial for symptomatic CAS.
- Optimal management for asymptomatic CAS remains under investigation.
Conclusions:
- Prompt carotid revascularization is vital for symptomatic CAS patients.
- Further research is needed to establish definitive guidelines for asymptomatic CAS.
- Ongoing trials are comparing revascularization with medical therapy alone.
Abstract:
Carotid Artery Stenosis (CAS) is a marker of systemic atherosclerosis and patients with CAS are at high risk of vascular events in multiple vascular locations, including ipsilateral ischemic stroke. Both medical and surgical therapies have been demonstrated effective in reducing this risk. The optimal management for patients with asymptomatic carotid artery stenosis remains controversial. In patients with symptomatic CAS ≥70%, CEA has been demonstrated to reduce the risk of stroke. With the risk of recurrent stroke being particularly high in the first 2 weeks after the first event, Carotid Endarterectomy (CEA) or carotid angioplasty with stenting provides maximal benefits to patients with symptomatic CAS ≥70% if performed within this «2-week» target. Several large ongoing trials are currently comparing the risks and benefits of carotid revascularization versus medical therapy alone.
Related Concept Videos
Mitral Stenosis III: Medical Management
Coronary Artery Disease IV: Preventive Measures
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Mitral Stenosis I: Introduction
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Gene Therapy


